Phase-specific cancer-immune model considering acquired resistance to therapeutic agents (Q2661016): Difference between revisions
From MaRDI portal
Set profile property. |
Set OpenAlex properties. |
||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1016/j.amc.2020.125555 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W3087668731 / rank | |||
Normal rank | |||
Revision as of 22:30, 19 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase-specific cancer-immune model considering acquired resistance to therapeutic agents |
scientific article |
Statements
Phase-specific cancer-immune model considering acquired resistance to therapeutic agents (English)
0 references
1 April 2021
0 references
cancer-immune model
0 references
immunotherapy
0 references
age-structured model
0 references
cancer phase-specific model
0 references
resistance to cancer treatment
0 references
pharmacokinetics and pharmacodynamics (PKPD)
0 references
